Endo International PLC

Pharmaceuticals
Ireland
Earnings Per Share Growth (%)-88%
Cost of Goods Sold (US$ Millions)$2,076
Current Liabilities (US$ Millions)$3,474
Total Assets (US$ Millions)$3,475
Long Term Debt$8,252
Return on Equity-62.96%
Revenue (US$ Millions)$3,269
Total Company Assets$19,350
Revenue Growth (%)13.61%
Net Income (US$ Millions)($1,495)
Earnings Per Share (US$)($88)
Total Equity (US$ Millions)$5,968
Profit Margin (%)-45.74%
Debt To Equity Ratio (%)1.38%
Inventory Turnover$745